DCM
IBB icon

Donaldson Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Donaldson Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,698
Closed -$209K – 152
2015
Q2 		$209K Buy
+1,698
New +$203K 0.03% 138

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Donaldson Capital Management's IBB Position: Q3 2015 in Review

Donaldson Capital Management sold out of iShares Biotechnology ETF (IBB) in Q3 2015, closing a stake of 1,698 shares — an estimated $209K sold.

Donaldson Capital Management first reported a position in IBB in Q2 2015 and held it in 1 quarter. The position peaked at $209K in Q2 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

  • Donaldson Capital Management reported no remaining iShares Biotechnology ETF position as of Q3 2015 after selling out during the quarter.
  • Donaldson Capital Management sold 1,698 iShares Biotechnology ETF shares in Q3 2015, an estimated $209K.
  • Donaldson Capital Management first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 1 quarter.
  • Donaldson Capital Management's iShares Biotechnology ETF position peaked at $209K in Q2 2015.
  • 415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on Donaldson Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.